Oasis Pharmaceuticals

Developer of therapeutics to treat inflammatory, fibrotic, and metabolic disorders

placeBoston, Massachusetts, United States calendar_todayFounded 2013 language pepducin.com

Innovation

1 patent family (1 granted) — focus: Chemistry & metallurgy; filing pace steady. Cited 321 times.

YearFilings
20171
20181
20211
20231
20241
20251

Investor mix

1 investor on record.

Investor typeCountShare
Other / undisclosed1100%
Coming soon